Tetrahydroquinoline derivatives and their use as Epac inhibitors

• 收藏
• 分享

专利权人:

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);UNIVERSITE PAUL SABATIER TOULOUSE III;UNIVERSITE PARIS-SUD;UNIVERSITE D'ORLEANS

发明人:

Lezoualc'h Frank,Fischmeister Rodolphe,Bisserier Malik,Bouyssou Pascal,Blondeau Jean-Paul,Courilleau Delphine

申请号：

US201715661143

公开号：

US10093627(B2)

申请日:

2017.07.27

申请国别(地区):

美国

年份:

2018

代理人:

W&C IP

摘要：

The invention relates to tetrahydroquinoline derivatives and their use in the treatment and/or the prevention of a disease wherein the Epac protein is involved, such as inflammation, cancer, vascular diseases, kidney diseases, cognitive disorders and cardiac diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/